SHC soterahealth.com: Business Value to Revenue

Public company logo of soterahealth.com (SHC)

Sotera Health Company (SHC) generates revenue from sterilization and testing for the pharmaceutical and medical sectors. As a key biosecurity operator, the firm ensures legal market access for products. High fixed costs create leverage for margin expansion as order volumes increase. The EV/Sales ratio reflects shifting growth phases, and the current metric stands at 5280.52, which helps in managing capital.

SHC Nordion Company Value to Revenue (11/23/2025 - 11/20/2026)

soterahealth.com - analytical breakdowns and key metrics (SHC)

- price and consensus price forecast:
- company stock capitalization data:
- money and cash flow information:
Fundamental company valuation:SHC - soterahealth.com
Product sample of Sotera Health Company

Sotera Health Company (SHC) leverages its monopoly status in the sterilization sector and high regulatory barriers to consistently increase contract values. An analysis of the Enterprise Value-to-Revenue (EV/Revenue) multiple, which combines market capitalization and net debt, helps assess current sales valuation relative to industry averages, identifying either an undervalued asset or risks of declining operating income for the issuer.

Competitor analysis

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio QuidelOrtho Inc. QDEL|EV/Sales Multiple OPKO Health Inc OPK|CareDx Inc - EV/Sales Multiple|Business Value to Revenue MRVI (Maravai)|FLGT: EV/Sales Multiple|LAB (Standard BioTools Inc.) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Cytek Biosciences Inc|Enterprise Value-to-Revenue Multiple OraSure OSUR|Company Value to Revenue XGN (Exagen Diagnostics)|Total Company Value-to-Revenue Ratio MDxHealth Inc.|Enterprise Value-to-Revenue Ratio Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Enterprise Value-to-Revenue Multiple|Insight Molecular Diagnostics Inc - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple trinitybiotech.com|PRPH (ProPhase) - Company Value to Revenue|Company Value to Revenue Ratio AIMD|Company Value to Revenue CODX|Enterprise Value-to-Revenue Multiple heartsciences.com HSCS|Enterprise Value-to-Revenue Ratio Biomerica Inc. (BMRA)|Total Company Value-to-Revenue Ratio Cardio Diagnostics Holdings|EV/Sales Multiple ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Enterprise Value-to-Revenue Multiple|bluejaydx.com - EV/Sales Multiple|Aspira Women's Health - Enterprise Value-to-Revenue Coefficient|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue